Abstract
The purpose of this study is to assess the early longitudinal metabolic effects including
insulin sensitivity in HIV-exposed uninfected (HEU) children compared to HIV-unexposed
uninfected (HUU) children; as well as to determine differences in the effects of neonatal
zidovudine (AZT) vs. nevirapine (NVP) prophylaxis on early longitudinal changes in insulin
sensitivity in the first 3 years of life.
